The intra-tumoural stroma in patients with breast cancer increases with age
Authors:
Open Access
- 18 September 2019
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 179 (1) , 37-45
Abstract
Purpose: The tumour microenvironment in older patients is subject to changes. The tumour–stroma ratio (TSR) was evaluated in order to estimate the amount of intra-tumoural stroma and to evaluate the prognostic value of the TSR in older patients with breast cancer (≥ 70 years). Methods: Two retrospective cohorts, the FOCUS study (N = 619) and the Nottingham Breast Cancer series (N = 1793), were used for assessment of the TSR on haematoxylin and eosin stained tissue slides. Results: The intra-tumoural stroma increases with age in the FOCUS study and the Nottingham Breast Cancer series (B 0.031, 95% CI 0.006–0.057, p = 0.016 and B 0.034, 95% CI 0.015–0.054, p < 0.001, respectively). Fifty-one per cent of the patients from the Nottingham Breast Cancer series < 40 years had a stroma-high tumour compared to 73% of the patients of ≥ 90 years from the FOCUS study. The TSR did not validate as an independent prognostic parameter in patients ≥ 70 years. Conclusions: The intra-tumoural stroma increases with age. This might be the result of an activated tumour microenvironment. The TSR did not validate as an independent prognostic parameter in patients ≥ 70 years in contrast to young women with breast cancer as published previously.Keywords
This publication has 37 references indexed in Scilit:
- Trends of population-based breast cancer survival in Germany and the US: Decreasing discrepancies, but persistent survival gap of elderly patients in GermanyBMC Cancer, 2012
- The prognostic value of tumour-stroma ratio in triple-negative breast cancerEuropean Journal of Surgical Oncology, 2012
- Lack of Survival Gain for Elderly Women with Breast CancerThe Oncologist, 2011
- Tumor–stroma ratio in the primary tumor is a prognostic factor in early breast cancer patients, especially in triple-negative carcinoma patientsBreast Cancer Research and Treatment, 2010
- Impact of aging on the biology of breast cancerCritical Reviews in Oncology/Hematology, 2008
- Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric OncologyThe Lancet Oncology, 2007
- Breast carcinoma in elderly womenCancer, 2004
- Endogenous Sex Hormones and Breast Cancer in Postmenopausal Women: Reanalysis of Nine Prospective StudiesJNCI: Journal of the National Cancer Institute, 2002
- Efficacy of cancer gene therapy in aging: adenocarcinoma cells engineered to release IL-2 are rejected but do not induce tumor specific immune memory in old miceGene Therapy, 2000
- Cell Proliferation in CarcinogenesisScience, 1990